11.61
前日終値:
$11.48
開ける:
$11.48
24時間の取引高:
2.27M
Relative Volume:
0.66
時価総額:
$1.50B
収益:
$628.25M
当期純損益:
$-78.55M
株価収益率:
-18.73
EPS:
-0.62
ネットキャッシュフロー:
$-29.73M
1週間 パフォーマンス:
+13.60%
1か月 パフォーマンス:
+8.81%
6か月 パフォーマンス:
+56.68%
1年 パフォーマンス:
-29.16%
Neogenomics Inc Stock (NEO) Company Profile
NEO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
NEO
Neogenomics Inc
|
11.61 | 1.49B | 628.25M | -78.55M | -29.73M | -0.62 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-30 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-07-29 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-05-15 | 開始されました | Guggenheim | Neutral |
| 2025-04-30 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-01-13 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2024-12-10 | 開始されました | Jefferies | Buy |
| 2024-05-01 | 再開されました | Craig Hallum | Buy |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-08-21 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-02-24 | アップグレード | The Benchmark Company | Hold → Buy |
| 2023-02-01 | アップグレード | Needham | Hold → Buy |
| 2022-08-26 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-22 | ダウングレード | Needham | Buy → Hold |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-03-29 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-03-29 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | 再開されました | Stephens | Overweight |
| 2021-12-16 | 開始されました | Cowen | Outperform |
| 2021-11-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-02-25 | 再開されました | Needham | Buy |
| 2021-02-25 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-12-11 | 再開されました | BTIG Research | Buy |
| 2020-10-28 | 繰り返されました | Needham | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-28 | 開始されました | Guggenheim | Buy |
| 2020-07-29 | 繰り返されました | Needham | Buy |
| 2020-06-25 | 開始されました | BofA/Merrill | Buy |
| 2020-04-21 | 再開されました | Stephens | Overweight |
| 2020-03-02 | 再開されました | Craig Hallum | Buy |
| 2020-02-28 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-05-01 | 繰り返されました | Needham | Buy |
| 2019-03-29 | 繰り返されました | Needham | Buy |
| 2019-01-03 | 開始されました | Needham | Buy |
| 2018-10-24 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | 開始されました | Leerink Partners | Outperform |
| 2018-05-02 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2017-08-24 | 開始されました | Gabelli & Co | Buy |
| 2016-12-15 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Neogenomics Inc (NEO) 最新ニュース
NeoGenomics, Fortrea, and Acadia Healthcare Shares Skyrocket, What You Need To Know - TradingView
First Week of January 2026 Options Trading For NeoGenomics (NEO) - Nasdaq
How NeoGenomics Inc. stock compares to market leadersWeekly Trade Review & Weekly Top Gainers Trade List - newser.com
Can NeoGenomics Inc. (NG9) stock sustain revenue momentumJuly 2025 Patterns & AI Powered Market Entry Strategies - newser.com
How hedge fund analytics apply to NeoGenomics Inc. stock2025 Year in Review & Free High Accuracy Swing Entry Alerts - newser.com
Is NeoGenomics Inc. stock a buy on dipsLayoff News & Smart Swing Trading Techniques - newser.com
Connor Clark & Lunn Investment Management Ltd. Takes Position in NeoGenomics, Inc. $NEO - MarketBeat
Is NeoGenomics Inc. (NG9) stock cheap by valuation metricsDividend Hike & Proven Capital Preservation Tips - newser.com
Earnings visualization tools for NeoGenomics Inc.2025 Earnings Impact & High Conviction Trade Alerts - newser.com
Is NeoGenomics Inc. (NG9) stock attractive for growth fundsMarket Activity Report & Daily Profit Focused Stock Screening - newser.com
Will NeoGenomics Inc. (NG9) stock beat value stocksJuly 2025 Snapshot & Smart Allocation Stock Tips - newser.com
Will earnings trigger a reversal in NeoGenomics Inc.Buy Signal & Safe Capital Growth Plans - newser.com
Will NeoGenomics Inc. (NG9) stock beat Nasdaq index returns2025 Historical Comparison & Precise Swing Trade Entry Alerts - newser.com
NeoGenomics at Stephens Conference: Strategic Growth Amid Pharma Challenges By Investing.com - Investing.com Canada
Will NeoGenomics Inc. stock maintain dividend yieldTrade Risk Report & Growth Oriented Trade Recommendations - newser.com
Price momentum metrics for NeoGenomics Inc. explainedJuly 2025 Closing Moves & Stepwise Entry and Exit Trade Signals - newser.com
Will NeoGenomics Inc. (NG9) stock announce a stock split2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com
Developing predictive dashboards with NeoGenomics Inc. dataMarket Risk Analysis & Long-Term Safe Investment Ideas - newser.com
Sector ETF performance correlation with NeoGenomics Inc.IPO Watch & Weekly Market Pulse Alerts - newser.com
How risky is NeoGenomics Inc. stock nowMarket Performance Summary & Verified Momentum Stock Alerts - newser.com
Avoiding Lag: Real-Time Signals in (NEO) Movement - news.stocktradersdaily.com
Neogenomics Inc (NEO) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):